These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 31591924

  • 1. Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study.
    Ventricelli DJ, Mathis SM, Foster KN, Pack RP, Tudiver F, Hagemeier NE.
    Subst Use Misuse; 2020; 55(3):349-357. PubMed ID: 31591924
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C, Unni E, Montuoro J, Ogborn DB.
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
    Wu LT, John WS, Ghitza UE, Wahle A, Matthews AG, Lewis M, Hart B, Hubbard Z, Bowlby LA, Greenblatt LH, Mannelli P, Pharm-OUD-Care Collaborative Investigators.
    Addiction; 2021 Jul; 116(7):1805-1816. PubMed ID: 33428284
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study.
    Löffler C, Koudmani C, Böhmer F, Paschka SD, Höck J, Drewelow E, Stremme M, Stahlhacke B, Altiner A.
    BMC Health Serv Res; 2017 Mar 21; 17(1):224. PubMed ID: 28327136
    [Abstract] [Full Text] [Related]

  • 8. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y, Sunderland B, Hughes J.
    Int J Pharm Pract; 2016 May 21; 24(3):180-8. PubMed ID: 26670327
    [Abstract] [Full Text] [Related]

  • 9. Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis.
    Hagemeier NE, Tudiver F, Brewster S, Hagy EJ, Ratliff B, Hagaman A, Pack RP.
    Subst Abus; 2018 Jan 02; 39(1):89-94. PubMed ID: 28799863
    [Abstract] [Full Text] [Related]

  • 10. The physician perspective on pharmacist-physician collaboration and trust.
    Amin S, McKeirnan KC.
    J Am Pharm Assoc (2003); 2022 Jan 02; 62(4):1304-1312. PubMed ID: 35346606
    [Abstract] [Full Text] [Related]

  • 11. Qualitative study to conceptualise a model of interprofessional collaboration between pharmacists and general practitioners to support patients' adherence to medication.
    Rathbone AP, Mansoor SM, Krass I, Hamrosi K, Aslani P.
    BMJ Open; 2016 Mar 16; 6(3):e010488. PubMed ID: 26983948
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study.
    Kang I, Urick B, Vohra R, Ives TJ.
    Res Social Adm Pharm; 2019 Aug 16; 15(8):1027-1031. PubMed ID: 31053466
    [Abstract] [Full Text] [Related]

  • 15. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
    Wheeler A, Crump K, Lee M, Li L, Patel A, Yang R, Zhao J, Jensen M.
    Res Social Adm Pharm; 2012 Aug 16; 8(3):179-92. PubMed ID: 21831724
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
    Marquis J, Schneider MP, Spencer B, Bugnon O, Du Pasquier S.
    Int J Clin Pharm; 2014 Oct 16; 36(5):1014-22. PubMed ID: 25139136
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA, Mekonnen AB, Aloudah NM, Alhawassi TM, Mc Namara K, Chaar B, Krass I, Saini B.
    Res Social Adm Pharm; 2020 Feb 16; 16(2):149-159. PubMed ID: 31027964
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.